COLA (Conferences On-Line Allergy) at 10 Years — Evolution of an Online Fellowship Curriculum

Dowling, Paul; Kader, Rubin; Portnoy, Jay M.

doi:10.1016/j.jaip.2019.06.025

Cited by 9 publications

(28 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…An example of a streaming video is Conferences On-Line Allergy. 39 Patients frequently access various online Web sites to obtain medical information, though the accuracy of such information is not always clear.…”

Section: Education For Patients and Providersmentioning

confidence: 99%

Telemedicine and emerging technologies for health care in allergy/immunology

Portnoy

Pandya

Waller

et al. 2020

Journal of Allergy and Clinical Immunology

Self Cite

View full text Add to dashboard Cite

Telemedicine (TM) has become a popular method of accessing medical services between providers and patients and is viewed as a cost-effective alternative to more traditional episodic faceto-face encounters. TM overcomes 2 barriers that patients face when seeking health care: distance and time. It is as effective as in-person visits for outpatient treatment of asthma, and it is a convenient way to provide inpatient consultations for patients when the allergist practices outside of the hospital. TM also has been used to manage patients with asthma in schools. Patients tend to be as satisfied with TM or they prefer TM over in-person visits, but infrequently they do prefer in-person visits. In addition to virtual visits using TM, there are several emerging technologies that are relevant to the practice of allergy/ immunology including electronic diaries (eg, symptoms and medication use), wearable technology (eg, to monitor activity and vital signs), remote patient monitoring (eg, environmental exposures and medication adherence) as well as electronic medical records augmented with clinical decision support. We believe that the use of TM, particularly when combined with information technologies such as electronic health records, has the potential to cause a transformational change in the way care is delivered by altering the process of interaction between patient and provider. TM addresses the shortage of allergy specialists in rural and underserved urban communities and facilitates patient access to allergy services. As patients take more control of their health care, use of TM is likely to increase because a large part of the move to adopt TM is driven by patient preference. (J Allergy Clin Immunol 2020;145:445-54.)

show abstract

Section: Education For Patients and Providersmentioning

confidence: 99%

Telemedicine and emerging technologies for health care in allergy/immunology

Portnoy

Pandya

Waller

et al. 2020

Journal of Allergy and Clinical Immunology

Self Cite

View full text Add to dashboard Cite

show abstract

“…Читайте нас на сайті: http://med expert.com.ua Вступ А лергічна патологія шкіри є однією з най актуальніших проблем сучасної педіат рії. За інформацією Всесвітньої організації охорони здоров'я (ВООЗ), у світі кожний п'я тий житель страждає від алергічних або псевдо алергічних реакцій, в Україні їх виявляють майже в кожної четвертої дитини [1,2,4,10]. Найпоширеніші алергодерматози: простий та алергічний контактні дерматити, атопічний дерматит, різні форми екземи, гостра та хроніч на алергічна кропив'янка, набряк Квінке, токсикодермії, багатоформна ексудативна ери тема (синдром Стівенса-Джонсона), гострий епідермальний некроліз (синдром Лаєлла), а також менш поширені дерматози, в патогене зі яких провідними є саме алергічні реакції [1,2,3,5,6,7,9].…”

Section: он мочульская тм косовскаяunclassified

“…Основними принципами лікуван ня алергодерматозів є комплексність та індиві дуальний підхід, урахування основних патоге нетичних ланок захворювання та його клініч них проявів. Лікування алергодерматозів передбачає системну і зовнішню терапію [2,4,6,9]. Алергодерматози, навіть якщо вони починаються гостро, часто набувають хроніч ного перебігу, а отже, потребують не лише ліку вання в період загострення, але й постійного контролю за їх перебігом для попередження рецидивів і подовження ремісії [2,4,6,7].…”

Section: он мочульская тм косовскаяunclassified

Systemic therapy of allergic dermatosis in children (literature review)

Mochulska¹,

Kosovska²

2021

MPU

View full text Add to dashboard Cite

Allergic pathology of skin is one of the most pressing problems of modern pediatry. The most common allergic dermatoses: simple and allergic contact dermatitis, atopic dermatitis, various forms of eczema, acute and chronic allergic urticaria, Quincke's edema, toxicodermias, multiforme exudative erythema (Stevens-Johnson syndrome), acute epidermal necrolysis (Lyell's syndrome). Many aspects of systemic treatment of allergic dermatoses in children are complex and controversial. The modern strategy of treatment of allergic dermatoses in children is based on the principles of evidence-based medicine. According to the international program documents EAACI (European Academy of Allergy and Clinical Immunology), AAAAI (American Academy of Allergy, Asthma & Immunology), PRACТALL (Practical Allergology Consensus Report) treatment of allergic dermatoses consists of: environmental control to eliminate allergenic and non-allergenic factors, skin care, systemic and local pharmacotherapy. Systemic pharmacotherapy includes using drugs of the following groups: antihistamines, glucocorticosteroids, membrane's stabilizators (kromons), leukotriene receptor antagonists, anti-IgE, cytostatics, sorbents, hepatoprotectors, probiotics, vitamins and minerals, antioxidants, sedative medications, enzymes, antibacterial, antifungal and antiviral, immunomodulatory and immunosuppressive medications. Purpose — to increase information on modern possibilities of systemic therapy of allergic dermatoses in children. Conclusions. Systemic pharmacotherapy of allergic dermatoses should be etiopathogenetic and influence the systemic mechanisms of allergic inflammation, which will help control the clinical course of the disease, reduce disability, improve the life quality of patients. No conflict of interest was declared by the authors. Key words: children, allergy, allergic dermatoses, systemic therapy, internal therapy.

show abstract

“…One can imagine the virtual classroom toppling institutional silos and bringing greater access to unique training opportunities across the nation. Examples include the American College of Allergy, Asthma & Immunology/Conferences On-Line Allergy lectures 31 shared on YouTube and regional videocast conferences in the DC-Maryland-Virginia area for complex immunodeficiency cases seen in Primary Immunodeficiency Clinic as models for collaborative educational endeavors. The move to virtual education may facilitate increased interaction, draw on unique strengths of individual training programs, and can create a nationwide community of allergy-immunology learners.…”

Section: Virtual Classroommentioning

confidence: 99%

The Future of Telehealth in Allergy and Immunology Training

Keswani

Brooks

Khoury

2020

The Journal of Allergy and Clinical Immunology: In Practice

View full text Add to dashboard Cite

Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre-including this research content-immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

show abstract

COLA (Conferences On-Line Allergy) at 10 Years — Evolution of an Online Fellowship Curriculum

Cited by 9 publications

References 11 publications

Telemedicine and emerging technologies for health care in allergy/immunology

Telemedicine and emerging technologies for health care in allergy/immunology

Systemic therapy of allergic dermatosis in children (literature review)

The Future of Telehealth in Allergy and Immunology Training

Contact Info

Product

Resources

About